Ovarian Cancer

U.S. government funds possible vaccine for ovarian cancer

Published in Women's Health Weekly, August 28th, 2003

Cancer researchers at the University of Arkansas for Medical Sciences (UAMS) have received more than $500,000 from the U.S. Department of Defense for development of a therapeutic vaccine for one of the deadliest diseases for women, ovarian cancer.

Women's cancer specialist Alessandro D. Santin of the UAMS College of Medicine is the principal investigator on the project. The grant of $505,123 for a 3-year research project is from the U.S. Army Medical Research and Material Command. Santin is a member of the Arkansas Cancer Research Center at UAMS.

Santin is developing a vaccine that contains powerful stimulator cells from the patient's own body that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2003-08-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry